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THERAPEUTIC FAILURE FOR ANTIRETROVIRAL DRUGS IN
HIV POSITIVE PATIENTS
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OBJECTIVES: To analyse the association between compliance
and therapeutic failure for antiretroviral drugs in HIV positive
patients, and to assess the accuracy of compliance measurement
as if it were a predictive test for treatment failure. METHODS:
Articles that reported the association between compliance, mon-
itored by electronic compliance-monitoring devices (ECMDs),
and treatment outcome with highly-active antiretroviral thera-
pies in HIV positive patients were identiﬁed. Data on compliance
(proportion of doses taken) and treatment failure, deﬁned as
viral load >400, or >500 copies of HIV RNA/ml, were extracted
for analysis. In most cases, compliance was measured on a con-
tinuous scale but categorised into quartiles, quintiles or arbi-
trarily chosen ranges. From these data, analyses of the receiver
operating characteristics (ROC) were made. Authors were con-
tacted in cases where appropriate data were not available. For
each study the area under the ROC curve and the 95% conﬁ-
dence interval were calculated by the nonparametric method. A
meta-analysis of all HIV trials identiﬁed was performed using a
ﬁxed-effect model. RESULTS: Six studies that presented the asso-
ciation between treatment failure and compliance (proportion of
doses taken) were identiﬁed. The results of the meta-analysis
gave a pooled area under the ROC curve of 0.74 (95% conﬁ-
dence interval 0.69–0.79) (test for heterogeneity X2 = 5.49, df =
5, p = 0.36). A mean area under the ROC curve of 0.74 suggests
that if we look at two patients, one a treatment success and the
other a treatment failure, the probability is 0.74 that the patient
failing therapy will have the positive test result, i.e. will be 
non-compliant. CONCLUSION: Reliable compliance history
obtained from ECMDs is a reasonable predictor of treatment
failure in HIV. The observed association between compliance
and virological failure, however, does not necessarily imply that
correction of compliance nulliﬁes these failures.
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OBJECTIVES: To culturally adapt the Hepatitis Quality of Life
Questionnaire (HQLQ) and assess its suitability for use in
English-speaking hepatitis B virus infected (HBV) patients in Sin-
gapore. METHODS: Two patient focus groups were conducted
to facilitate the cultural adaptation of the HQLQ, a disease-
targeted, multi-item scales HRQoL questionnaire. Reliability
was assessed using Cronbach’s alpha coefﬁcients (for internal
consistency) and intraclass correlation coefﬁcients (for test retest
reliability). Item-to-scale correlation (corrected for overlap) was
assessed using Spearman’s rank correlations (ρ) between scale
scores and their constituent items. For known-groups validity,
statistically signiﬁcant differences in all scale scores among dif-
ferent categories of HBV patients, namely asymptomatic carrier,
chronic hepatitis B, compensated cirrhosis, decompensated cir-
rhosis, hepatocellular carcinoma and post-liver transplants were
tested using one-way ANOVA. Healthy volunteers with no sig-
niﬁcant disease from the general population were recruited as
controls. Convergent and divergent construct validities were
tested in 10 and 14 a priori hypotheses respectively and the cor-
relations were assessed using Spearman’s rank correlation coef-
ﬁcients (ρ). RESULTS: The culturally adapted questionnaire was
tested in 298 HBV patients. The reliability coefﬁcients were
excellent with α > 0.7 for all scales and acceptable correlation
coefﬁcients were obtained for 10 of the 12 scales. Item-to-scale
correlations were good with most items highly correlated with
their hypothesized scales. For known-group validity, a compari-
son of mean scores at different stages of the disease showed sig-
niﬁcantly lower HRQoL scores in cases of more advanced stages
of disease in most scales. Convergent and divergent construct
validities were supported by the presence of hypothesized corre-
lations between the HQLQ and the EQ-5D domains (8 of 10
hypotheses for convergent construct validity and all hypotheses
for divergent construct validity were fulﬁlled). CONCLUSION:
The culturally adapted HQLQ has good validity and reliability,
making it a potentially useful outcome measure in the evaluation
of HBV patients in Singapore.
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OBJECTIVES: The present large-scale survey had a main objec-
tive of demonstrating the prevalence of chronic pain, but also
sought to explore the impact it has on their lives, their percep-
tion of the attitudes of others towards their pain, treatments
received and the adequacy of treatment. It addressed the fol-
lowing aims: (a) estimating the prevalence of chronic pain in
Turkey, (b) quantifying causes of chronic pain, (c) exploring the
demographics of chronic pain, (d) exploring the impact of
chronic pain on individuals, quality of life and daily activities,
(e) understanding current treatment practices and levels of satis-
faction with treatment, (f) exploring the attitudes of individuals
towards their pain and their experiences of pain, (g) exploring
how individuals with chronic pain perceive the attitudes of their
families, friends, colleagues and doctors. METHODS: Face to
face survey (4036 person, 7 geograﬁcal districts of Turkey) was
undertaken to explore the prevalence, severity, treatment and
impact of chronic pain in Turkey. RESULTS: In-depth interviews
with 300 respondents with chronic pain showed: 43% had mod-
erate pain, 20% had severe pain, 37% had suffered with pain
for two to 15 years, 39% had been pain because of head and
neck, 32% of them had pain because of back, 33% lost job
responsibility (demotion), 21% lost their job and 16% changed
jobs because of their pain. 20% of them were diagnosed with
depression. Two-thirds were taking prescription analgesics:
naproxen (34%), metamizol (24%), paracetamol (20%). Aspirin
was the most preffered drug for patients. When we compare
Turkey and Europe, while 67% of Turkish patients were taking
prescription analgesics, in Europe that number was 52%. CON-
CLUSION: Thirty-seven percent of Turkish adults had pain.
9.5% of Turkish adults had chronic pain—lower than that mea-
sured in 18 European countries—seriously affecting the quality
of their social and working lives.
